These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 20103042
21. The Role of Posterior Vitreous Detachment and Vitreomacular Adhesion in Patients With Age-Related Macular Degeneration. Ilim O, Akkin C, Oztas Z, Nalcaci S, Afrashi F, Degirmenci C, Mentes J. Ophthalmic Surg Lasers Imaging Retina; 2017 Mar 01; 48(3):223-229. PubMed ID: 28297034 [Abstract] [Full Text] [Related]
27. Vitreomacular traction after macular translocation surgery in a highly myopic eye. Yamada M, Ishikawa K, Terasaki H. Retina; 2005 Jun 01; 25(2):221-3. PubMed ID: 15689819 [No Abstract] [Full Text] [Related]
32. DIABETES ALTERS THE MAGNITUDE OF VITREOMACULAR ADHESION. Nesmith BL, Palacio AC, Schaal Y, Gupta A, Schaal S. Retina; 2017 Apr 01; 37(4):749-752. PubMed ID: 27471829 [Abstract] [Full Text] [Related]
33. Appearance of age-related macular degeneration in vitrectomized and nonvitrectomized eyes: an intraindividual case study. Schulze S, Neugebauer A, Kroll P. Acta Ophthalmol; 2012 May 01; 90(3):244-7. PubMed ID: 20491689 [Abstract] [Full Text] [Related]
34. Quantification of error in optical coherence tomography central macular thickness measurement in wet age-related macular degeneration. Ghazi NG, Kirk T, Allam S, Yan G. Am J Ophthalmol; 2009 Jul 01; 148(1):90-6.e2. PubMed ID: 19403111 [Abstract] [Full Text] [Related]
35. Optical coherence tomographic findings of vitreomacular traction syndrome with macular hole retinal detachment. Tanimura M, Shinoda K, Takaki Y, Kimoto K, Yamada K, Nakatsuka K. Clin Exp Ophthalmol; 2008 May 01; 36(4):386-8. PubMed ID: 18700929 [No Abstract] [Full Text] [Related]
37. Spectral-domain optical coherence tomography use in macular diseases: a review. Wolf S, Wolf-Schnurrbusch U. Ophthalmologica; 2010 May 01; 224(6):333-40. PubMed ID: 20453539 [Abstract] [Full Text] [Related]
38. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Bom Aggio F, Eid Farah M, Melo GB. Acta Ophthalmol Scand; 2006 Oct 01; 84(5):713-4. PubMed ID: 16965511 [No Abstract] [Full Text] [Related]
39. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Lee SJ, Koh HJ. Ophthalmology; 2011 Jan 01; 118(1):101-10. PubMed ID: 20678805 [Abstract] [Full Text] [Related]